Skip to main content
ARTRYA LIMITED logo

ARTRYA LIMITED — Investor Relations & Filings

Ticker · AYA ISIN · AU0000182412 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 322 across all filing types
Latest filing 2023-09-12 Regulatory Filings
Country AU Australia
Listing ASX AYA

About ARTRYA LIMITED

https://artrya.com

Artrya Limited is a medical technology company focused on the development of artificial intelligence solutions for the detection and management of coronary artery disease. The company's flagship platform, Artrya Salix, utilizes deep learning algorithms to automate the analysis of Computed Tomography Coronary Angiography (CTCA) scans. This technology is designed to assist clinicians by identifying and quantifying key markers of heart disease, including coronary artery stenosis and high-risk vulnerable plaque, which are often difficult to detect through manual review. By providing rapid, non-invasive, and objective assessments, the platform aims to improve diagnostic accuracy, streamline clinical workflows, and support early intervention strategies for patients at risk of major adverse cardiac events. The software integrates into existing clinical environments to provide point-of-care decision support for radiologists and cardiologists.

Recent filings

Filing Released Lang Actions
Change of Registry Address Notification 1 page 64.1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement titled 'CHANGE OF REGISTRY ADDRESS NOTIFICATION' dated 13 September 2023. It informs about the change of the registry office address for Computershare Investor Services Pty Limited, effective from 18 September 2023. There is no financial data, report content, or detailed analysis present. The document is a brief regulatory announcement about administrative changes, not a financial report or detailed filing. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-09-12 English
Issue of Shares on Exercise of Options and Cleansing Notice 2 pages 186.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 4 September 2023 regarding the issuance of 110,000 ordinary shares on exercise of options by Artrya Limited. It includes a secondary trading notice pursuant to paragraph 708A(5)(e) of the Corporations Act 2001, which is a regulatory compliance notice related to the share issue. The content focuses on the issuance of shares and related regulatory disclosures, not on financial results, management changes, or other report types. The document length is 3788 characters, which is relatively short and typical for a capital or financing update announcement. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2023-09-03 English
Application for quotation of securities - AYA 8 pages 30.4KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the number of securities, issue dates, and classifications under ASX rules. This is a formal announcement related to changes in the company's capital structure, specifically the issuance and quotation of new shares resulting from option exercises. It does not contain financial statements, management discussion, or audit information. Therefore, it fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings.
2023-09-03 English
Appendix 4E and Annual Financial Report - 30 June 2023 62 pages 1.7MB
Annual Report Classification · 100% confidence The document is titled 'Appendix 4E' and 'Annual Financial Report for the Year Ended 30 June 2023' for Artrya Limited. It includes detailed financial statements such as the consolidated statement of financial position, profit or loss, changes in equity, cash flows, notes to the financial statements, directors' report, auditor's report, and auditor's independence declaration. The document covers a full fiscal year (1 July 2022 to 30 June 2023) and contains comprehensive financial data and management discussion. It is clearly the official yearly report covering company activity and full financial performance. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2023-08-30 English
Clarification Announcement 2 pages 147.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX market release dated 16 August 2023, providing a clarification announcement regarding the company's previously released Quarterly Activities Report and Appendix 4C for the quarter ending 30 June 2023. It focuses on explaining variances in the Use of Funds table, referencing Listing Rule 4.7C.2. The document does not contain actual financial statements or substantive financial data itself but rather clarifies information related to a quarterly report. It is a regulatory announcement clarifying prior disclosures rather than the report itself. The document length is 4122 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and clarifications that do not fit other specific categories.
2023-08-15 English
Rescheduled Investor Call 1 page 65.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 25 July 2023 from Artrya Limited regarding a rescheduled investor call to discuss the Quarterly Q4 FY23 results. It mentions the call is to provide an update and apologizes for an incorrect meeting link in a previously issued Quarterly Activity Report. The document does not contain actual financial data or detailed financial statements but is an announcement about the scheduling of a conference call related to quarterly results. The document length is short (1994 characters) and serves as a notification rather than a full report or transcript. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not contain the full call transcript or the quarterly report itself.
2023-07-24 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.